COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions

doi:10.1001/jama.2020.7869

. 2020 Jun 9;323(22):2245-2246.

doi: 10.1001/jama.2020.7869.

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions

Robert D Kirkcaldy¹, Brian A King¹, John T Brooks¹

Affiliations

PMID: 32391855
PMCID: PMC8596300
DOI: 10.1001/jama.2020.7869

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions

Robert D Kirkcaldy et al. JAMA. 2020.

. 2020 Jun 9;323(22):2245-2246.

doi: 10.1001/jama.2020.7869.

Authors

Robert D Kirkcaldy¹, Brian A King¹, John T Brooks¹

Affiliation

¹ US Centers for Disease Control and Prevention, Atlanta, Georgia.

PMID: 32391855
PMCID: PMC8596300
DOI: 10.1001/jama.2020.7869

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Cited by

T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.
Macchia I, La Sorsa V, Ciervo A, Ruspantini I, Negri D, Borghi M, De Angelis ML, Luciani F, Martina A, Taglieri S, Durastanti V, Altavista MC, Urbani F, Mancini F. Macchia I, et al. Biomolecules. 2024 Sep 26;14(10):1217. doi: 10.3390/biom14101217. Biomolecules. 2024. PMID: 39456150 Free PMC article.
Mathematical modelling of COVID-19 transmission dynamics in a partially comorbid community.
Ssebuliba J, Nakakawa JN, Ssematimba A, Mugisha JYT. Ssebuliba J, et al. Partial Differ Equ Appl Math. 2022 Jun;5:100212. doi: 10.1016/j.padiff.2021.100212. Epub 2021 Nov 24. Partial Differ Equ Appl Math. 2022. PMID: 38621002 Free PMC article.
COVID-19 natural herd immunity and risk of neuropsychiatric disorders.
Losilla-Rodríguez B, Maldonado N, Moreno-Mellado E, López-Díaz Á. Losilla-Rodríguez B, et al. Rev Psiquiatr Salud Ment. 2020 Oct-Dec;13(4):228-229. doi: 10.1016/j.rpsm.2020.07.002. Epub 2020 Aug 24. Rev Psiquiatr Salud Ment. 2020. PMID: 38620321 Free PMC article. No abstract available.
An Outbreak Preparedness and Mitigation Approach in Home Health and Personal Home Care During the COVID-19 Pandemic.
Mills WR, Sender S, Reynolds K, Lichtefeld J, Romano N, Price M, Phipps J, White L, Howard S, Domico R. Mills WR, et al. Home Health Care Manag Pract. 2020 Nov;32(4):229-233. doi: 10.1177/1084822320933567. Home Health Care Manag Pract. 2020. PMID: 38602996 Free PMC article.
Causes and Effects of COVID-19 Vaccine Hesitancy Among Pregnant Women and its Association with Adverse Maternal, Placental, and Perinatal Outcomes.
Moriarty KL, Oyenuga RO, Olafuyi O, Schwartz DA. Moriarty KL, et al. Yale J Biol Med. 2024 Mar 29;97(1):73-84. doi: 10.59249/LPOQ5146. eCollection 2024 Mar. Yale J Biol Med. 2024. PMID: 38559465 Free PMC article. Review.

See all "Cited by" articles

References

1. Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. Published online March 28, 2020. doi:10.1093/cid/ciaa344 - DOI - PMC - PubMed
1. Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. Published online April 1, 2020. doi:10.1038/s41586-020-2196-x - DOI - PubMed
1. To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574. doi:10.1016/S1473-3099(20)30196-1 - DOI - PMC - PubMed
1. Wu L-P, Wang N-C, Chang Y-H, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562–1564. doi:10.3201/eid1310.070576 - DOI - PMC - PubMed
1. Payne DC, Iblan I, Rha B, et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016;22 (10):1824–1826. doi:10.3201/eid2210.160706 - DOI - PMC - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

CC999999/ImCDC/Intramural CDC HHS/United States

LinkOut - more resources

Full Text Sources

[1] Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. Published online March 28, 2020. doi:10.1093/cid/ciaa344 - DOI - PMC - PubMed

[2] Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. Published online March 28, 2020. doi:10.1093/cid/ciaa344 - DOI - PMC - PubMed

[3] Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. Published online April 1, 2020. doi:10.1038/s41586-020-2196-x - DOI - PubMed

[4] Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. Published online April 1, 2020. doi:10.1038/s41586-020-2196-x - DOI - PubMed

[5] To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574. doi:10.1016/S1473-3099(20)30196-1 - DOI - PMC - PubMed

[6] To KK, Tsang OT, Leung WS, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20(5):565–574. doi:10.1016/S1473-3099(20)30196-1 - DOI - PMC - PubMed

[7] Wu L-P, Wang N-C, Chang Y-H, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562–1564. doi:10.3201/eid1310.070576 - DOI - PMC - PubMed

[8] Wu L-P, Wang N-C, Chang Y-H, et al. Duration of antibody responses after severe acute respiratory syndrome. Emerg Infect Dis. 2007;13(10):1562–1564. doi:10.3201/eid1310.070576 - DOI - PMC - PubMed

[9] Payne DC, Iblan I, Rha B, et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016;22 (10):1824–1826. doi:10.3201/eid2210.160706 - DOI - PMC - PubMed

[10] Payne DC, Iblan I, Rha B, et al. Persistence of antibodies against Middle East respiratory syndrome coronavirus. Emerg Infect Dis. 2016;22 (10):1824–1826. doi:10.3201/eid2210.160706 - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions

Affiliation

COVID-19 and Postinfection Immunity: Limited Evidence, Many Remaining Questions

Authors

Affiliation

Conflict of interest statement

Similar articles

Cited by

References

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources